Fate Therapeutics Inc (FATE)

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1.
Redmile Group

Jeremy Green

12,629,737 $1,148,422 13.9%
2.
Casdin Capital

Eli Casdin

3,050,000 $277,337 8.21%
3.
Farallon Capital

Thomas Steyer

3,000,000 $272,790 -4% 1.77%
4.
ARK Investment Management

Catherine D. Wood

2,901,700 $263,852 +102% 0.7%
5. 1,108,640 $100,809 -58% 0.02%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$85.50 327,485 Large Shareholder, Director 12,957,222 2021-01-08 Filing
$28.31 1,412,928 Large Shareholder, Director 12,629,737 2020-06-11 Filing
$17.50 857,143 Large Shareholder, Director 11,216,809 2019-09-16 Filing
$13.50 3,703,704 Large Shareholder, Director 10,359,666 2018-09-25 Filing
$2.66 37,593 Officer 37,593 2016-11-23 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$103.16 5,547 Officer, Director 393,793 2021-02-18 Filing
$102.26 8,602 Officer, Director 399,340 2021-02-18 Filing
$101.42 2,602 Officer, Director 407,942 2021-02-18 Filing
$100.48 1,848 Officer, Director 410,544 2021-02-18 Filing
$99.08 1,401 Officer, Director 412,392 2021-02-18 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 410,425 $37,319,945 0.01%
2. 11,773 $1,070,519 0%
3. 10,959 $997,000 0.15%
4. 7,604,904 $691,514 0.06%
5. 6,671,541 $606,642 0.02%
News See All